Compound Summary
Compound Name: | Ginsenoside RG1 |
Compound CID: | 441923 |
Synonyms: | Ginsenoside RG1 22427-39-0 Sanchinoside C1 Panaxoside A Ginsenoside A2 More... |
Iupac Name: | (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
InChI: | InChI=1S/C42H72O14/c1-20(2)10-9-13-42(8,56-37-34(52)32(50)30(48)25(19-44)55-37)21-11-15-40(6)28(21)22(45)16-26-39(5)14-12-27(46)38(3,4)35(39)23(17-41(26,40)7)53-36-33(51)31(49)29(47)24(18-43)54-36/h10,21-37,43-52H,9,11-19H2,1-8H3/t21-,22+,23-,24+,25+,26+,27-,28-,29+,30+,31-,32-,33+,34+,35-,36+,37-,39+,40+,41+,42-/m0/s1 |
InChIKey: | YURJSTAIMNSZAE-HHNZYBFYSA-N |
Canonical Smiles: | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C)OC6C(C(C(C(O6)CO)O)O)O)C |
Isomeric Smiles: | CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)O)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C |
Molecular Weight: | 801 |
Molecular Formula: | C42H72O14 |
Molecular Weight: | 801 |
Molecular Formula: | C42H72O14 |
Hydrogen Bond Donor Count: | 10 |
Hydrogen Bond Acceptor Count: | 14 |
Rotatable Bond Count: | 10 |
Heavy Atom Count: | 56 |
Complexity: | 1410 |
Ginsenoside RG1 | Ginsenoside RG1 |
---|---|
Ginsenoside RG1 |
22427-39-0 |
Sanchinoside C1 |
Panaxoside A |
Ginsenoside A2 |
Panaxoside Rg1 |
Sanchinoside Rg1 |
UNII-PJ788634QY |
(3beta,6alpha,12beta)-3,12-Dihydroxydammar-24-ene-6,20-diyl bis-beta-D-Glucopyranoside |
(20S)-ginsenoside Rg1 |
CHEBI:67987 |
PJ788634QY |
MFCD00210293 |
ginsenoside-Rg1 |
Ginsenoside g1 |
CHEMBL501637 |
Panaxoside A; |
Ginsenoside A2; |
Ginsenoside Rg1; |
EINECS 244-989-9 |
BIDD:ER0075 |
Dammarane, -D-glucopyranoside |
SCHEMBL19875635 |
DTXSID70945111 |
HMS3885M12 |
HY-N0045 |
RG1 |
6-(Hexopyranosyloxy)-3,12-dihydroxydammar-24-en-20-yl hexopyranoside |
Ginsenoside Rg1, analytical standard |
s3923 |
(6)-beta-D-Glucopyranosyl-(20)-beta-D-glucopyranosyl-20S-protopanaxatriol |
AKOS037514672 |
ZINC238809655 |
CCG-270492 |
CS-3832 |
DB06750 |
BS-16671 |
N1613 |
Y0090 |
C08946 |
427G390 |
A816192 |
Q-100285 |
Q2276594 |
7-HYDROXY-2-OXO-2H-CHROMENE-3-CARBOXYLICACIDAMIDE |
Ginsenoside Rg1, primary pharmaceutical reference standard |
Ginsenoside Rg1, United States Pharmacopeia (USP) Reference Standard |
(3b,6a,12b)-3,12-dihydroxydammar-24-ene-6,20- diylbis(beta-d-glucopyranoside) |
(3beta,6alpha,12beta)-3,12-Dihydroxydammar-24-ene-6,20-diylbis(beta-D-glucopyranoside) |
beta-D-Glucopyranoside, (3beta,6alpha,12beta)-3,12-dihydroxy dammar-24-ene-6,20-diylbis- |
beta-D-Glucopyranoside, (3beta,6alpha,12beta)-3,12-dihydroxydammar-24-ene-6,20-diyl bis- |
(2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-((S)-6-methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hept-5-en-2-yl)hexadecahydro-1H-cyclopentaaphenanthren-6-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
(3beta,alpha,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl beta-D-glucopyranoside |
Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 150 | ug/mL | 8.8 | S | N2 | 33683565 | Active |
Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | 8.8 | 1 | 1 |